|
|
| PMID |
|
|
| TITLE |
|
| Association between polygenic liability to depression and lifetime depression in at-risk adolescents. |
|
| ABSTRACT |
|
|
|
| Internalising symptoms including depression, anxiety and somatic symptoms in adolescence are common. They can be transient, but they can also persist and progress to major depressive disorder (MDD) Polygenic risk scores for major depression (MD-PGS) may help identify which symptomatic adolescents are at greatest risk of later disorder. In a mega-analysis of two longitudinal population-based cohorts from Brisbane, Australia, we investigated whether polygenic liability to depression improves risk stratification among adolescents with elevated internalising symptoms. Internalising symptoms were assessed at age 14, lifetime MDD was assessed in young adulthood using the Composite International Diagnostic Interview, and MD-PGS were generated using summary statistics from the latest Psychiatric Genomics Consortium major depression genome-wide association study, excluding Australian cohorts. Analyses focused on comparisons between individuals in the top decile of risk and those in the remaining 90% of each cohort. A total of 302 cases with lifetime MDD and 1693 controls were included. Compared with adolescents outside the highest decile of internalising symptoms, those in the top decile at age 14 had a more than two-fold increased odds of lifetime MDD (OR = 2.56, 95% CI 1.92-3.49, p = 5.4 × 10 ). Individuals in the top decile of MD-PGS also showed increased odds of lifetime MDD compared with the remaining 90% (OR = 3.45, 95% CI 2.53-4.71, p = 4.4 × 10 ¹⁵). Adolescents who were simultaneously in the top decile of both internalising symptoms and MD-PGS had an approximately eight-fold increased odds of lifetime MDD compared with individuals outside the top decile for both risk factors (OR = 8.58, 95% CI 4.04-18.26, p = 1.2 × 10 ⁵). These findings indicate that polygenic risk scores for depression may have particular clinical utility for stratifying risk among adolescents already presenting with elevated internalising symptoms, identifying a subgroup at very high risk for later major depressive disorder. |
| © 2026. The Author(s). |
|
| DATE PUBLISHED |
|
|
| HISTORY |
|
| PUBSTATUS |
PUBSTATUSDATE |
| received |
2025/05/23 |
| accepted |
2026/09/16 |
| revised |
2026/07/22 |
| medline |
2026/10/07 05:31 |
| pubmed |
2026/10/07 05:31 |
| entrez |
2026/10/06 23:43 |
|
| AUTHORS |
|
| NAME |
COLLECTIVENAME |
LASTNAME |
FORENAME |
INITIALS |
AFFILIATION |
AFFILIATIONINFO |
| Byrne EM |
|
Byrne |
Enda M |
EM |
|
Child Health Research Centre, The University of Queensland, Brisbane, Australia. enda.byrne@uq.edu.au. |
| Gillespie NA |
|
Gillespie |
Nathan A |
NA |
|
Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA. |
| Najman JM |
|
Najman |
Jake M |
JM |
|
School of Public Health, The University of Queensland, Brisbane, Australia. |
| Henders AK |
|
Henders |
Anjali K |
AK |
|
Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia. |
| Mitchell BL |
|
Mitchell |
Brittany L |
BL |
|
QIMR Berghofer Medical Research Institute, Brisbane, Australia. |
| Dwyer D |
|
Dwyer |
Dominic |
D |
|
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia. |
| Hartmann S |
|
Hartmann |
Simon |
S |
|
Adelaide Medical School, Discipline of Psychiatry, The University of Adelaide, Adelaide, Australia. |
| Cavve BS |
|
Cavve |
Blake S |
BS |
|
Telethon Kids Institute, The University of Western Australia, Perth, Australia. |
| Amminger GP |
|
Amminger |
G Paul |
GP |
|
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia. |
| Clark S |
|
Clark |
Scott |
S |
|
Adelaide Medical School, Discipline of Psychiatry, The University of Adelaide, Adelaide, Australia. |
| Gao C |
|
Gao |
Caroline |
C |
|
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia. |
| Lin A |
|
Lin |
Ashleigh |
A |
|
Telethon Kids Institute, The University of Western Australia, Perth, Australia. |
| Schmaal L |
|
Schmaal |
Lianne |
L |
|
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia. |
| Thompson A |
|
Thompson |
Andrew |
A |
|
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia. |
| Wood SJ |
|
Wood |
Stephen J |
SJ |
|
Centre for Human Brain Health, University of Birmingham, Birmingham, UK. |
| Wigman JTW |
|
Wigman |
J T W |
JTW |
|
Department of Psychiatry, Interdisciplinary Center for Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. |
| Yung AR |
|
Yung |
Alison R |
AR |
|
Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Melbourne, Australia. |
| Medland SE |
|
Medland |
Sarah E |
SE |
|
QIMR Berghofer Medical Research Institute, Brisbane, Australia. |
| Crouse JJ |
|
Crouse |
Jacob J |
JJ |
|
Youth Mental and Technology Health Team, Brain & Mind Centre, The University of Sydney, Camperdown, Australia. |
| Scott J |
|
Scott |
Jan |
J |
|
Universite de Paris, Paris, France. |
| Scott JG |
|
Scott |
James G |
JG |
|
Child and Youth Mental Health Service, Children's Health Queensland Hospital and Health Service, Brisbane, Australia. |
| Williams GM |
|
Williams |
Gail M |
GM |
|
School of Public Health, The University of Queensland, Brisbane, Australia. |
| Nelson B |
|
Nelson |
Barnaby |
B |
|
Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia. |
| Martin NG |
|
Martin |
Nicholas G |
NG |
|
QIMR Berghofer Medical Research Institute, Brisbane, Australia. |
| Hickie IB |
|
Hickie |
Ian B |
IB |
|
Youth Mental and Technology Health Team, Brain & Mind Centre, The University of Sydney, Camperdown, Australia. |
| Wray NR |
|
Wray |
Naomi R |
NR |
|
Queensland Brain Institute, The University of Queensland, Brisbane, Australia. |
| Middeldorp CM |
|
Middeldorp |
Christel M |
CM |
|
Levvel, Academic Centre for Child and Adolescent Psychiatry, Amsterdam, The Netherlands. |
|
| INVESTIGATORS |
|
|
| JOURNAL |
|
| VOLUME: |
| ISSUE: |
| TITLE: Molecular psychiatry |
| ISOABBREVIATION: Mol Psychiatry |
| YEAR: 2026 |
| MONTH: Oct |
| DAY: 06 |
| MEDLINEDATE: |
| SEASON: |
| CITEDMEDIUM: Internet |
| ISSN: 1476-5578 |
| ISSNTYPE: Electronic |
|
| MEDLINE JOURNAL |
|
| MEDLINETA: Mol Psychiatry |
| COUNTRY: England |
| ISSNLINKING: 1359-4184 |
| NLMUNIQUEID: 9607835 |
|
| PUBLICATION TYPE |
|
| PUBLICATIONTYPE TEXT |
| Journal Article |
|
| COMMENTS AND CORRECTIONS |
|
|
| GRANTS |
|
| GRANTID |
AGENCY |
COUNTRY |
| 1198304 |
Department of Health | National Health and Medical Research Council (NHMRC) |
|
|
| GENERAL NOTE |
|
|
| KEYWORDS |
|
|
| MESH HEADINGS |
|
|
| SUPPLEMENTARY MESH |
|
|
| GENE SYMBOLS |
|
|
| CHEMICALS |
|
|
| OTHER ID's |
|
|
|
